Mary F. Hoult

Mary F. Hoult

58 year
Commercial Services
Health Technology
Consumer Services

Profile

Ms. Molly Hoult is a Principal at Fletcher Spaght Venture Partners LLC and Independent Director at HTG Molecular Diagnostics, Inc. She is on the Board of Directors at Fletcher Spaght, Inc. and HTG Molecular Diagnostics, Inc. Prior to rejoining the firm in 2009, Ms. Hoult spent over a decade in marketing and business development roles for various biotechnology and medical device firms including: ZymoGenetics, Blue Heron Biotechnology and NeoPath (which subsequently merged to form TriPath and then was acquired by BD Diagnostics).
Ms. Hoult holds an MBA from the Stanford Graduate School of Business and a BA in Biology and Environmental Studies from Dartmouth College.

Former positions of Mary F. Hoult

CompaniesPositionEnd
Promidian Private Equity Investor 2021-08-31
Private Equity Investor 2021-08-31
Private Equity Investor 2019-03-31
HTG MOLECULAR DIAGNOSTICS, INC. Director/Board Member 2016-07-31
Xcyte Therapies, Inc. Director/Board Member -
See the detail of Mary F. Hoult's experience

Training of Mary F. Hoult

Dartmouth College Undergraduate Degree
Stanford Graduate School of Business Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mary F. Hoult's experience

Connections

24

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
HTG MOLECULAR DIAGNOSTICS, INC.

Commercial Services

Private companies7

Health Technology

Commercial Services

Xcyte Therapies, Inc.

Health Technology

Health Technology

Commercial Services

Commercial Services

Promidian

See company connections